School of Medicine


Showing 801-850 of 5,029 Results

  • Stephanie Chow

    Stephanie Chow

    Clinical Assistant Professor, Obstetrics & Gynecology - Gynecologic Oncology

    BioDr. Chow is a fellowship-trained gynecologic oncologist. She is a clinical assistant professor in the Department of Obstetrics and Gynecology, Division of Gynecologic Oncology.

    She treats the full spectrum of gynecologic cancers, including cervical, endometrial, ovarian, vaginal, and vulvar. She emphasizes minimally invasive treatment and performs laparoscopic and robotic surgery.

    Dr. Chow works closely with radiation oncology, genetics, and other oncologic specialists in a multidisciplinary setting to provide high quality, evidence-based, and individualized care. Dr. Chow is a strong advocate for patient education and strives to deliver compassionate care to patients and their families.

    Dr. Chow has conducted extensive clinical research. Her work has focused on the role of the sentinel lymph node biopsy technique for gynecologic cancer, therapeutic vaccines for ovarian cancer, the impact of race on the development of uterine cancer, and other topics. She has published in Molecular Cancer Therapeutics, Gynecologic Oncology, Scientific Reports, and other peer-reviewed journals.

    Dr. Chow has also won numerous honors and awards for her scholarship and research achievements. In fellowship, she earned the AACR Doreen J. Putrah Cancer Research Foundation Scholar-In-Training Award. She was also awarded the AAGL Recognition of Excellence in Minimally Invasive Gynecology.

    Dr. Chow is a member of the Society of Gynecologic Oncology (SGO), American Association for Cancer Research (AACR), American Association of Gynecologic Laparoscopists (AAGL), and American College of Obstetricians and Gynecologists (ACOG).

  • Kamilee Christenson, MD

    Kamilee Christenson, MD

    Adjunct Clinical Assistant Professor, Obstetrics & Gynecology - General

    Current Research and Scholarly InterestsImproving access to effective birth control. Improving access to safe abortions.

  • Antonios Chronopoulos

    Antonios Chronopoulos

    Instructor, Medicine - Gastroenterology & Hepatology

    Current Research and Scholarly InterestsMy research focuses on understanding how extracellular matrix (ECM) remodeling in liver fibrosis, particularly in the context of aging, diabetes, and metabolic-associated steatohepatitis (MASH), disrupts tissue mechanical homeostasis and drives hepatocellular carcinoma pathogenesis. The goal is to translate these mechanobiological insights into novel therapies targeting mechanotransduction to prevent or reverse fibrosis and improve patient outcomes with liver cancer and other desmoplastic tumors

  • Alvina Dor-Yan Chu

    Alvina Dor-Yan Chu

    Adjunct Clinical Assistant Professor, Medicine - Immunology & Rheumatology

    BioAlvina Chu, MD, is an adjunct clinical faculty member within the Division of Immunology and Rheumatology. She has practiced rheumatology for more than 10 years, specializing in treatment of a wide range of chronic inflammatory conditions including rheumatoid arthritis, lupus, vasculitis, and gout.

    She holds a longstanding scientific interest in immunology, especially the role of B-cell signaling mechanisms in lupus and other autoimmune diseases.

    In addition to taking care of patients in clinic and in the hospital, Dr. Chu enjoys teaching and mentoring fellows, residents, and medical students.

  • Andrew Chu, MD, MPH, MBA

    Andrew Chu, MD, MPH, MBA

    Clinical Assistant Professor, Emergency Medicine

    BioDr. Chu is a board-certified emergency medicine physician and clinical assistant professor in the Department of Emergency Medicine. He is passionate about integrating lean startup methodologies into daily academic practice and has a decade of experience leading multi-disciplinary teams in designing, developing, and launching award-winning healthcare technologies. Dr. Chu is currently working with his colleagues to build AI solutions that will improve clinical operations for the emergency department.

    He is also part of the Stanford EM Partners Program (STEPP), where he evaluates and executes on promising academic-industry partnerships. He is also an active committee member and former co-chair for the Stanford EM Innovation Conference, the premier virtual conference on AI and innovation for the acute care space.

    He completed his residency in emergency medicine at the Harvard affiliated Mass General Brigham program. He received his applied research fellowship in healthcare innovation at Harvard Medical School. He also completed the Stanford Biodesign Faculty Fellowship. He pursued a medical degree at Boston University, a Master of Public Health (MPH) degree at Harvard, and a Master of Business Administration (MBA) degree at the Quantic School of Business and Technology.

    He is a member of the American College of Emergency Physicians, American Academy of Emergency Medicine, and Society of Academic Emergency Medicine.

  • Constance Chu, MD

    Constance Chu, MD

    Professor of Orthopaedic Surgery (Sports Medicine)

    BioDr. Constance R. Chu is Professor and Vice Chair Research, in the Department of Orthopedic Surgery at Stanford University. She is also Director of the Joint Preservation Center and Chief of Sports Medicine at the VA Palo Alto. Previously, she was the Albert Ferguson Endowed Chair and Professor of Orthopaedic Surgery at the University of Pittsburgh. She is a clinician-scientist who is both principal investigator of several projects funded by the National Institutes of Health and who has been recognized as a Castle-Connelly/US News and World Report “Top Doctor” in Orthopedic Surgery as well as on Becker’s list of Top Knee Surgeons in the United States. Her clinical practice focuses on the knee: primarily restoration and reconstruction of the ACL, menisci and cartilage. She graduated from the U.S. Military Academy at West Point and earned her medical degree from Harvard Medical School.

    As Director of the multi-disciplinary Joint Preservation Center structured to seamlessly integrate the latest advances in biologics, mechanics, and imaging with comprehensive patient centered musculoskeletal and orthopedic care, Dr. Chu aims to develop a new model for health care delivery, research and education with an emphasis on health promotion and prevention. Cornerstones of this program include teamwork and a focus on personalized medicine. A central goal is to transform the clinical approach to osteoarthritis from palliation to prevention. In addition to optimizing clinical operations, outstanding research is critical to developing more effective new treatments. Towards this end, Dr. Chu is leading innovative translational research from bench to bedside in three main areas: quantitative imaging and biomarker development for early diagnosis and staging of joint and cartilage injury and degeneration; cartilage tissue engineering and stem cell based cartilage repair; and molecular and biological therapies for joint restoration and joint rejuvenation. Her research efforts have led to more than 30 professional awards and honors to include a Kappa Delta Award, considered to be the highest research honor in Orthopedic Surgery.

    Dr. Chu also regularly holds leadership and committee positions in major professional organizations such as the American Association of Orthopedic Surgeons (AAOS) and the American Orthopedic Association (AOA). In her subspecialty of Orthopedic Sports Medicine, she is a past President of the Forum Sports Focus Group, a member of the Herodicus Society of leaders in Sports Medicine, and immediate past Chair of the American Orthopedic Society for Sports Medicine (AOSSM) Research Council. She is alumnus of the AOA American, British, Canadian (ABC) and the AOSSM Traveling Fellowships.

  • Derek Chu, MD

    Derek Chu, MD

    Clinical Associate Professor, Dermatology
    Clinical Associate Professor (By courtesy), Pediatrics

    BioDerek Chu, M.D., is Clinical Associate Professor of Dermatology and Pediatrics at Lucile Packard Children's Hospital. He completed his medical school and residency training at the University of Pennsylvania, followed by a pediatric dermatology fellowship at UCSF. Dr. Chu's clinical interests encompass a wide array of topics within pediatric dermatology, including vascular tumors and malformations, inflammatory skin diseases, dermato-oncology, neonatal dermatology, and procedural dermatology.
    Email: derekchu@stanford.edu

  • Gilbert Chu

    Gilbert Chu

    Professor of Medicine (Oncology) and of Biochemistry

    Current Research and Scholarly InterestsAfter shuttering the wet lab, we have focused on: a point-of-care device to measure blood ammonia and prevent brain damage; a human protein complex that juxtaposes and joins DNA ends for repair and V(D)J recombination; and strategies for teaching students and for reducing selection bias in educational programs.

  • Lawrence Chu, MD, MS

    Lawrence Chu, MD, MS

    Professor of Anesthesiology, Perioperative and Pain Medicine (MSD)

    Current Research and Scholarly InterestsI have two lines of research, one involving educational informatics and use of technology in postgraduate medical education and another involving NIH-funded work in patient-oriented clinical research regarding opioid use and physiologic responses associated with acute and chronic exposure in humans.

    For a full description of my educational informatics work, please see my website aim.stanford.edu.

    My clinical research focuses on the study opiate-induced hyperalgesia in patients suffering from chronic pain.

    I am currently conducting an NIH-funded five year double-blinded randomized controlled clinical study (NIGMS award 1K23GM071400-01) that prospectively examines the following hypotheses: 1) pain patients on chronic opioid therapy develop dose-dependent tolerance and/or hyperalgesia to these medications over time, 2) opiate-induced tolerance and hyperalgesia develop differently with respect to various types of pain, 3) opioid-induced hyperalgesia occurs independently of withdrawal phenomena, and 4) opiate-induced tolerance and hyperalgesia develop differently based on gender and/or ethnicity.

    The study is the first quantitative and prospective examination of tolerance and hyperalgesia in pain patients and may have important implications for the rational use of opioids in the treatment of chronic pain.

  • Steven Chu

    Steven Chu

    William R. Kenan Jr. Professor, Professor of Molecular and Cellular Physiology and of Energy Science and Engineering

    Current Research and Scholarly InterestsSynthesis, functionalization and applications of nanoparticle bioprobes for molecular cellular in vivo imaging in biology and biomedicine. Linear and nonlinear difference frequency mixing ultrasound imaging. Lithium metal-sulfur batteries, new approaches to electrochemical splitting of water. CO2 reduction, lithium extraction from salt water

  • Weihan Chu

    Weihan Chu

    Clinical Assistant Professor, Medicine

    BioAlex Weihan Chu, M.D. serves as a Clinical Assistant Professor at Stanford School of Medicine and is the Associate Chief Medical Officer and Vice President of Quality, Health Equity, and Clinical Affairs at Stanford Health Care Tri-Valley.

    Dr. Chu has been a dedicated member of SHC Tri-Valley since 2015, joining as a Hospital Medicine physician after completing his residency at Stanford Hospital. He is board-certified in Internal Medicine and Clinical Informatics. Since 2016, he has served as the Medical Informatics Director, a role he continues to oversee, ensuring that technology enhances clinical workflows and patient care.

    Dr. Chu has held multiple leadership roles, including serving on the Medical Executive Committee and as Vice Chief of Medicine. He previously served as Associate Chief Medical Officer for Patient Safety, Infection Control & Accreditation, Regulatory & Licensing, where he played a key role in supporting Joint Commission surveys, ensuring CDPH compliance, and leading hospital safety initiatives to address regulatory findings.

    In 2024, Dr. Chu transitioned to his current role, the Associate Chief Medical Officer and Vice President for Quality, Health Equity, and Clinical Affairs where he is responsible for coordinating a comprehensive system of quality monitoring and improvement to achieve excellent patient care. He works closely with Kathleen Carrothers, Senior Director of Quality Management and Performance Improvement, to oversee clinical outcomes, data management, and performance improvement initiatives. He also leads health equity efforts and manages physician agreements, ensuring sustained high-quality care and strategic physician engagement.

    Dr. Chu brings expertise in physician engagement, clinical oversight, clinical informatics, and quality improvement. His experience in driving multi-disciplinary change and advancing health equity to aligns with the hospital’s mission and vision.

    Outside of work, Dr. Chu enjoys hiking, scuba diving, photography, and exploring the latest advancements in technology.

  • Ian Chua

    Ian Chua

    Clinical Associate Professor, Pediatrics

    BioIan Chua, MD, MHPE, MBA is a bicoastal pediatric hospitalist and clinical associate professor of pediatrics at Stanford Children’s Health (Palo Alto, CA) and Children’s National Medical Center (Washington, DC). He completed his residency at Stanford Children’s with concentrations in medical education and quality improvement. He obtained his Masters’ in Health Professions Education at University of Illinois in Chicago. He currently co-directs the Quality and Leadership Training (QUILT) program in the department of pediatrics as well as the PHM Leadership Rotation. He also directs the ACGME Fellows’ Common Core Curriculum, the PHM Fellowship Medical Education Pathway, and the Pediatric residency medical education pathway at Children’s National Medical Center. His interests have been in educational scholarship and professional development of transitional learners including junior faculty. Nationally, he has been involved in shaping the national PHM fellows' conference and is the current co-chair for the AAP SOHM Emerging Leaders Conference.

  • Katrin Chua

    Katrin Chua

    Professor of Medicine (Endocrinology, Gerontology and Metabolism)
    On Partial Leave from 02/01/2026 To 08/31/2026

    Current Research and Scholarly InterestsOur lab is interested in understanding molecular processes that underlie aging and age-associated pathologies in mammals. We focus on a family of genes, the SIRTs, which regulate stress resistance and lifespan in lower organisms such as yeast, worms, and flies. In mammals, we recently uncovered a number of ways in which SIRT factors may contribute to cellular and organismal aging by regulating resistance to various forms of stress. We have now begun to characterize the molecular mechanisms by which these SIRT factors function. In particular, we are interested in how SIRT factors regulate chromatin, the molecular structure in which the DNA of mammalian genomes is packaged, and how such functions may link genome maintenance to stress resistance and aging.

  • Cynthia Chuang

    Cynthia Chuang

    Clinical Professor, Radiation Oncology - Radiation Physics

    BioEducation:

    1990-B.S., Bioelectrical Engineering (6-1B), Massachusetts Institute of Technology, Cambridge, MA

    1992-M.S., Bioengineering, University of Pennsylvania, Philadelphia, PA

    1994-M.S., Nuclear Engineering (NMR Spectroscopy), Massachusetts Institute of Technology, Cambridge, MA

    1999-Ph.D., Nuclear Engineering (Boron Neutron Capture Therapy), Massachusetts Institute of Technology, Cambridge, MA

    2001-Postdoctoral Fellowship (Peregrine Project), Lawrence Livermore National Laboratory

    2003-Medical Physics Residency, University of California, San Francisco (joint 3.5-year postdoctoral and residency program)


    Academic Appointments:

    2003 - 2005-Clinical Instructor, Radiation Oncology, University of California, San Francisco, San Francisco, California

    2005 - 2009-Assistant Adjunct Professor, Radiation Oncology, University of California, San Francisco, San Francisco, California

    2009 - 2013-Assistant Professor In Residence, Radiation Oncology, University of California, San Francisco, San Francisco, California

    2013 - 2017-Associate Professor In Residence, Radiation Oncology, University of California, San Francisco, San Francisco, California

    2017 - 2018-Associate Professor of Clinical Radiation Oncology, University of California, San Francisco, San Francisco, California

    2019 - 2023-Clinical Associate Professor, Department of Radiation Oncology, Clinical Educator Line, Stanford University, Stanford, CA

    2023- Present-Clinical Professor, Department of Radiation Oncology, Clinical Educator Line, Stanford University, Stanford, CA

  • Henry Chubb

    Henry Chubb

    Clinical Associate Professor, Pediatrics - Cardiology

    Current Research and Scholarly Interestshttps://www.researchgate.net/profile/Henry_Chubb

  • Benjamin I. Chung

    Benjamin I. Chung

    Professor of Urology and, by courtesy, of Epidemiology and Population Health

    Current Research and Scholarly InterestsRenal cell carcinoma and prostate cancer outcomes research and epidemiology.

  • Lorinda Chung

    Lorinda Chung

    Professor of Medicine (Immunology and Rheumatology) and, by courtesy, of Dermatology

    Current Research and Scholarly InterestsMy research interests focus on all aspects of systemic sclerosis. I am currently involved in clinical, translational, and epidemiologic research in these areas, and dedicate a substantial portion of my research time to investigator-initiated and multi-center clinical trials of novel therapeutics for the treatment of systemic sclerosis.

  • Philip Chung

    Philip Chung

    Instructor, Anesthesiology, Perioperative and Pain Medicine

    BioI am a general anesthesiologist and healthcare AI researcher. My areas of research focus on large language model applications in perioperative medicine and anesthesiology, particularly for clinical reasoning, risk prediction, and documentation generation to improve clinician workflows.

    In addition to practicing at the Stanford hospital, I am also a member of Nima Aghaeepour's laboratory. See my CV and Google Scholar on the bottom right of this page for more information.

  • Kirk Churukian

    Kirk Churukian

    Clinical Assistant Professor, Surgery - Plastic & Reconstructive Surgery

    BioKirk A. Churukian MD, FACS is board certified by the American Board of Plastic Surgery. Dr. Churukian completed training in general surgery, plastic surgery, and hand surgery. He was board certified in general surgery and is currently board certified in plastic surgery.

    Dr. Churukian is a member of several local, state, and national professional societies and has practiced in the Los Gatos/San Jose areas for more than 20 years. He tries to bring a friendly, creative, and patient focused approach to his cosmetic and reconstructive surgery practice.

    In addition to his private cosmetic practice, Dr. Churukian serves the community as a trauma specialist at San Jose Regional Medical Center. At this level II Trauma Center, he specializes in facial and orbital fracture repair and complex reconstructive surgery of the trunk and extremities. He also maintains an ongoing commitment to enhancing self-image with breast reconstruction for cancer survivors.

    Dr. Churukian grew up as a first generation eldest son of Armenian parents in Southern California and attended the University of Southern California, graduating with a degree in Psychobiology. Always interested in athletics, He participated in swimming and water polo throughout high school and played club water polo in college. This interest in aquatics was transferred to his children, all of whom are swimmers, and two of whom are avid water polo players. He currently resides in Menlo Park, California and is currently still married to his first wife ;-). He enjoys supporting Stanford athletics, except when the USC Trojans come to town!

  • Karlene Cimprich

    Karlene Cimprich

    Professor of Chemical and Systems Biology and, by courtesy, of Biochemistry
    On Partial Leave from 03/01/2026 To 04/30/2026

    Current Research and Scholarly InterestsGenomic instability contributes to many diseases, but it also underlies many natural processes. The Cimprich lab is focused on understanding how mammalian cells maintain genomic stability in the context of DNA replication stress and DNA damage. We are interested in the molecular mechanisms underlying the cellular response to replication stress and DNA damage as well as the links between DNA damage and replication stress to human disease.

  • Andrea Cipriano

    Andrea Cipriano

    Instructor, Obstetrics & Gynecology - Reproductive Biology
    Instructor, OB-GYN/Reproductive, Perinatal and Stem Cell Biology Research

    BioDr Andrea Cipriano is an instructor at the Stem Cell Institute and at the Ob/Gyn department at Stanford School of medicine. Since the beginning of his career he was driven by a deep interest in the complexities of life emerging from just a single cell, harboring all the instructions to produce a fully functional organism. His academic journey began with a Bachelor's in Biotechnology and progressed to a Master's in Genomic Biotechnology, where he delved into the intricate world of RNA. During his PhD, Andrea focused on long non-coding RNAs and their pivotal role in cell differentiation, a topic that continues to fascinate him in his current research. He works in the Sebastiano lab, and he is directing several projects, including studying the transcription factor TBX1 during development of the Pharyngeal endoderm, and exploring the impact of time on Chromatin Structure, particularly in the context of aging and its potential reversal. As an instructor, Andrea has been teaching for 4 years at the intensive CIRM stem cell class biology course. Teaching is a big passion that fuels his academic pursuits. His dedication to education stems from a deep-seated belief in the transformative power of knowledge, which is what initially propelled him into the academic world.

  • Robin Cisco, MD

    Robin Cisco, MD

    Clinical Associate Professor, Surgery - General Surgery

    BioDr. Robin Cisco is a board certified general surgeon and fellowship-trained endocrine surgeon. She specializes in surgery of the thyroid, parathyroid and adrenal glands and has expertise in lymph node dissection for thyroid cancer. Dr Cisco received her medical degree at Duke University before moving to Stanford for general surgery residency. During her residency, she completed a two-year research fellowship in surgical oncology, with a focus on cancer immunology.

    After residency, she completed an endocrine surgery fellowship with the internationally recognized UCSF Division of Endocrine Surgery. She is the author of multiple publications related to endocrine surgery and surgical oncology and has an interest in minimally invasive approaches to thyroid, parathyroid and adrenal surgery. She is currently the Physician Leader of Stanford's Endocrine Oncology Cancer Care Program (CCP).

    Dr. Cisco focuses on providing outstanding surgical care in an environment that is supportive of her patients and their families. She enjoys patient education and preoperative counseling, and seeks to lessen the anxiety that often comes with a recommendation for surgery. She currently sees patients both in San Jose at Stanford's Cancer Center South Bay and in Palo Alto in the Endocrine Oncology and Surgery clinic.

  • Stephanie Cizek

    Stephanie Cizek

    Clinical Associate Professor, Obstetrics & Gynecology
    Clinical Associate Professor (By courtesy), Pediatrics

    BioI am a Pediatric and Adolescent Gynecologist, which combines my passion for gynecology with my love of working with children and young adults (and the people who care for them!). My approach to providing care is a collaborative one: my patients are individually unique and special, and their care should be tailored to be the best fit for them.

    Prior to joining the Stanford faculty, I completed a fellowship in Pediatric and Adolescent Gynecology, From an academic standpoint, my current research focuses include: Gynecologic care for Oncology Survivors including Onco-Fertility and vulvovaginal graft-versus-host disease; gynecologic care of patients with Anorectal Malformations; Differences of Sex Development, Intersex conditions, and reproductive tract differences; and surgical care in pediatric gynecology.

  • Thomas Clandinin

    Thomas Clandinin

    Shooter Family Professor

    Current Research and Scholarly InterestsThe Clandinin lab focuses on understanding how neuronal circuits assemble and function to perform specific computations and guide behavior. Taking advantage of a rich armamentarium of genetic tools available in the fruit fly, combined with imaging, physiology and analytical techniques drawn from systems neuroscience, we examine a variety of visual circuits.

  • Daniel Clark, MD, MPH

    Daniel Clark, MD, MPH

    Clinical Assistant Professor, Medicine - Cardiovascular Medicine
    Clinical Assistant Professor, Pediatrics - Cardiology

    BioDr. Clark is a board-certified, fellowship-trained cardiologist with the Adult Congenital Heart Program at Stanford Health Care. He is also a clinical assistant professor with dual appointments in the Division of Cardiovascular Medicine, Department of Medicine and the Division of Cardiology, Department of Pediatrics at Stanford University School of Medicine.

    Dr. Clark specializes in the diagnosis and treatment of adult congenital heart disease (ACHD) and the management of congenital and acquired heart disease in children. His clinical focus involves the combined use of cardiac magnetic resonance (CMR) and other imaging techniques to evaluate patients with known or suspected cardiovascular disease. Dr. Clark’s extensive training and experience with these techniques include multiple fellowships in adult cardiology, cardiovascular imaging, and ACHD.

    Dr. Clark is currently a co-investigator on multiple research studies. During his fellowship, he received a training grant from the National Institutes of Health enabling evaluation of the ability of CMR to diagnose COVID-19-associated heart inflammation among college athletes. He currently uses CMR to assess heart transplant outcomes in donors positive for hepatitis C virus. Dr. Clark also received a research grant from the Adult Congenital Heart Disease Association supporting a randomized, controlled clinical trial of cardiac rehabilitation among patients with Fontan failure.

    Dr. Clark serves as a peer reviewer for multiple prestigious journals, including The New England Journal of Medicine, Circulation, Journal of the American College of Cardiology, and Journal of the American Heart Association (JAHA). He serves on the editorial board for both JAHA and Circulation: Cardiovascular Imaging. He is also a member of numerous professional medical societies, including the American College of Cardiology, the American Heart Association, and the Adult Congenital Heart Association.

  • David Clark

    David Clark

    Professor of Anesthesiology, Perioperative and Pain Medicine (MSD)

    BioMy career is dedicated to improving the safety, effectiveness and availability of pain relief. Both the needs and opportunities in these areas are limitless. I have had the good fortune of working as a clinician, teacher and scientist at Stanford University and the Palo Alto VA hospital for more than two decades.

    Much of my time is spent on laboratory, translational and clinical research. In the laboratory, we are pursuing several projects related to the questions of why pain sometimes becomes chronic after injuries and why opioids lose their effectiveness over time. Alterations in endogenous pain control mechanisms and the involvement of the adaptive system of immunity are central to these investigations. We would like to find ways to maximize functional recovery after surgery and other forms of trauma while minimizing the risks of analgesic use. This work involves local, national and international collaborations. Clinical trials work involves establishing the efficacy of novel forms of analgesic therapy as well as the comparative effectiveness of long-established approaches to controlling common forms of pain such as low back pain. This spectrum of pain-related pursuits continues to evolve with the rapid expansion of the field.

  • John Clarke

    John Clarke

    Clinical Professor, Medicine - Gastroenterology & Hepatology

    BioDr. John Clarke recently joined the Gastroenterology & Hepatology Division at Stanford University as Director of the Esophageal Program. He previously spent 17 years in Baltimore, including 9 years on the faculty at Johns Hopkins University where he was an Associate Professor and at various times Director of Esophageal Motility, Director of Gastrointestinal Motility, Clinical Director of the Johns Hopkins Center for Neurogastroenterology, and Clinical Director of the Gastroenterology & Hepatology Division at Johns Hopkins Bayview Medical Center.

    His career has combined research, education and clinical care. His clinical areas of expertise include achalasia, dysphagia, eosinophilic esophagitis, esophageal dysmotility, gastroesophageal reflux disease, gastroparesis, GI-manifestations of scleroderma and GI dysmotility. While at Johns Hopkins University, he was inducted into The Miller-Coulson Academy for Clinical Excellence, an institutional honor society for master clinicians at the time limited to 50 members across the entire university.

    From an education standpoint, he has lectured in over a dozen countries, authored over 25 textbook chapters and serves on the educational affairs committee of the American College of Gastroenterology. He has also won several major teaching awards, including The Johns Hopkins University Alumni Association Award for Excellence in Teaching, given to one faculty member per year in the entire School of Medicine.

    His research has focused on optimization and characterization of diagnostic studies to evaluate motility disorders, as well the relationship between therapeutic endoscopic techniques and treatment of motility disorders. He was an investigator on the NIH Gastroparesis Consortium and is also a former recipient of the AGA Don Castell Award.

  • Michael F. Clarke, M.D.

    Michael F. Clarke, M.D.

    Karel H. and Avice N. Beekhuis Professor of Cancer Biology

    Current Research and Scholarly InterestsDr. Clarke maintains a laboratory focused on two areas of research: i) the control of self-renewal of normal stem cells and diseases such as cancer and hereditary diseases; and ii) the identification and characterization of cancer stem cells. His laboratory is investigating how perturbations of stem cell regulatory machinery contributes to human disease. In particular, the laboratory is investigating epigenetic regulators of self renewal, the process by which stem cells regenerate themselves.

  • Shoa L. Clarke, MD, PhD

    Shoa L. Clarke, MD, PhD

    Assistant Professor of Medicine (Stanford Prevention Research Center) and of Pediatrics (Cardiology)

    BioDr. Clarke is a preventive cardiologist and a physician-scientist focused on disease prevention. He earned his undergraduate degree in human biology from the Division of Nutritional Sciences at Cornell University before obtaining his MD and PhD (genetics) from Stanford University School of Medicine. He has completed clinical training in internal medicine (Brigham & Women’s Hospital), pediatrics (Boston Children’s Hospital), and cardiovascular medicine (Stanford Hospital), and he is board certified in all three specialties. His research is focused on 1) understanding complex disease genetics in diverse populations, 2) integrating monogenic and polygenic risk with clinical risk, 3) large-scale phenotyping using the electronic health record and medical images. His clinical practice focuses on identifying risk factors for cardiovascular disease with the goal of promoting health and longevity through evidence-based personalized treatment. He is interested in developing family-centric approaches for the treatment of adults and children carrying genetic risk for disease.

  • Stephanie Clarke

    Stephanie Clarke

    Clinical Assistant Professor, Psychiatry and Behavioral Sciences - Child & Adolescent Psychiatry and Child Development

    BioDr. Stephanie Clarke is a Licensed Clinical Psychologist and Clinical Assistant Professor of Psychiatry and Behavioral Sciences at Stanford University School of Medicine. Dr. Clarke is an expert in the treatment of suicidal and self-harming behavior in adolescents, with additional expertise in evidence-based treatment of trauma and restrictive eating disorders in adolescents. She is intensively trained in Dialectical Behavior Therapy (DBT), currently the only well-established treatment for self-harming adolescents at high risk for suicide. Dr. Clarke is an Attending Psychologist and supervisor in Stanford’s Adolescent DBT Program, Eating Disorders Clinic, and Comprehensive Care Program (CCP, inpatient unit for medical issues related to disordered eating), where she specialized in seeing complex cases with multiple diagnoses (e.g., comorbid Anorexia Nervosa and suicidality/self-harm). She was the Stanford Psychologist in the DBT Intensive Outpatient Program, RISE, a collaboration between Stanford and Children’s Health Council, where she was in charge of training and supervision of psychology trainees. Dr. Clarke also provides education and training to psychology and psychiatry trainees in DBT, Acceptance and Commitment Therapy (ACT), suicidality, self-harm, mood disorders, eating disorders, and trauma. Dr. Clarke has given numerous talks, trainings, and lectures and has co-authored several publications on the topics of adolescent suicide, self-harming behavior, and DBT.

    In 2020, Dr. Clarke was the recipient of the Department of Psychiatry and Behavioral Science's Clinical Innovation and Service Award. Dr. Clarke was also awarded funding from the Professional Leadership Development Awards Program for the 20-21 academic year, which supports the career development of department faculty who exhibit particular promise in advancing into leadership roles in academic medicine. Dr. Clarke has been funded by a grant from the Department of Psychiatry and Behavioral Sciences and the Maternal and Child Health Research Institute to study the safety and feasibility of providing exposure-based trauma treatment to suicidal teens in stage I DBT.

    Dr. Clarke also maintains a small private practice, where she provides consultation, parent coaching, and individual therapy for adolescents and adults using DBT, FBT, exposure and response prevention, ACT, compassion-focused, and other CBT and evidence-based approaches.

  • Carol Clayberger

    Carol Clayberger

    Professor (Research) of Pediatrics, Emerita

    Current Research and Scholarly InterestsOur group uses molecular biology, biochemistry, and cellular immunology to investigate the activation and effector function of T lymphocytes. Research in the laboratory is currently focused on three areas: granulysin, a lytic molecule expressed late (7-12 days) after T cell activation; identification of correlates of immunity in diseases such as tuberculosis; and tolerance. The long term goal of this work is to develop new ways to treat human disease.

  • Michael Cleary

    Michael Cleary

    Lindhard Family Professor of Pediatric Cancer Biology and Professor of Pathology, Emeritus

    Current Research and Scholarly InterestsThe role of oncoproteins in cancer and development; molecular and cellular biology of hematologic malignancies; targeted molecular therapies of cancer.

  • William Clusin, MD

    William Clusin, MD

    Associate Professor of Medicine (Cardiovascular Medicine), Emeritus

    Current Research and Scholarly InterestsCardiac action potentials; tissue culture, voltage, clamp technique; role of calcium in ischemia arrhythmias; coronary, artery disease; myocardial infarction.

  • Maria Inmaculada Cobos Sillero

    Maria Inmaculada Cobos Sillero

    Associate Professor of Pathology

    Current Research and Scholarly InterestsOur lab uses cellular and molecular methods, single-cell technology, and quantitative histology to study human neurodegenerative diseases. Current projects include:

    - Using single-cell RNA-sequencing to understand selective vulnerability and disease progression in human Alzheimer’s disease brain

    - Investigating mechanisms of tau-related neurodegeneration in human brain

    - Studying the neocortical and limbic systems in Diffuse Lewy Body Disease (DLBD) at the single cell level

  • Jennifer R. Cochran

    Jennifer R. Cochran

    Vice President for SLAC National Accelerator Laboratory and for Strategic Initiatives, Addie and Al Macovski Professor, Professor of Bioengineering and, by courtesy, of Chemical Engineering

    Current Research and Scholarly InterestsMolecular Engineering, Protein Biochemistry, Biotechnology, Cell and Tissue Engineering, Molecular Imaging, Chemical Biology